J Urenjak1, T P Obrenovitch. Show Affiliations » 1. Department of Neurological Surgery, Institute of Neurology, London, UK.
Abstract
Entities: Disease
Mesh: See more » AnimalsBrain/cytologyBrain/drug effectsBrain/metabolismBrain Ischemia/drug therapyBrain Ischemia/physiopathologyBrain Ischemia/prevention & controlCalcium Channels/drug effectsCentral Nervous System/drug effectsCentral Nervous System/metabolismDown-RegulationEnergy MetabolismHomeostasisHumansNeurons/cytologyNeurons/drug effectsNeurons/metabolismNeuroprotective Agents/administration & dosageNeuroprotective Agents/pharmacologyNeuroprotective Agents/therapeutic usePhosphorylationSaxitoxin/pharmacologySaxitoxin/therapeutic useSodium/metabolismSodium Channels/drug effectsSodium Channels/metabolismTetrodotoxin/pharmacologyTetrodotoxin/therapeutic use
Substances: See more » Calcium ChannelsNeuroprotective AgentsSodium ChannelsSaxitoxinTetrodotoxinSodium
Year: 1996 PMID: 8685246
Source DB: PubMed Journal: Pharmacol Rev ISSN: 0031-6997 Impact factor: 25.468